Inhibition of herpesvirus and influenza virus replication by blocking polymerase subunit interactions

Antiviral Res. 2013 Sep;99(3):318-27. doi: 10.1016/j.antiviral.2013.05.014. Epub 2013 Jun 6.

Abstract

Protein-protein interactions (PPIs) play a key role in many biological processes, including virus replication in the host cell. Since most of the PPIs are functionally essential, a possible strategy to inhibit virus replication is based on the disruption of viral protein complexes by peptides or small molecules that interfere with subunit interactions. In particular, an attractive target for antiviral drugs is the binding between the subunits of essential viral enzymes. This review describes the development of new antiviral compounds that inhibit herpesvirus and influenza virus replication by blocking interactions between subunit proteins of their polymerase complexes.

Keywords: Antiviral therapy; Herpesvirus; Influenza virus; Protein–protein interaction; Viral polymerase.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antiviral Agents / pharmacology*
  • DNA-Directed RNA Polymerases / genetics
  • DNA-Directed RNA Polymerases / metabolism*
  • Herpesviridae / drug effects*
  • Herpesviridae / enzymology*
  • Herpesviridae / genetics
  • Herpesviridae / physiology
  • Herpesviridae Infections / drug therapy
  • Herpesviridae Infections / virology
  • Humans
  • Influenza, Human / drug therapy
  • Influenza, Human / virology
  • Orthomyxoviridae / drug effects*
  • Orthomyxoviridae / enzymology*
  • Orthomyxoviridae / genetics
  • Orthomyxoviridae / physiology
  • Protein Binding / drug effects
  • Protein Subunits / genetics
  • Protein Subunits / metabolism
  • Viral Proteins / genetics
  • Viral Proteins / metabolism*

Substances

  • Antiviral Agents
  • Protein Subunits
  • Viral Proteins
  • DNA-Directed RNA Polymerases